Young M. Kim

Gyeonggi-do, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 147 publications

Corrigendum to "ABRL8301, a novel 2-methoxyestradiol derivative, mitigates progressive pulmonary fibrosis by downregulating 11β-hydroxysteroid dehydrogenase 1" [Eur. J. Pharmacol. 1032 (2026) 179224].

Corrigendum to "ABRL8301, a novel 2-methoxyestradiol derivative, mitigates progressive pulmonary fibrosis by downregulating 11β-hydroxysteroid dehydrogenase 1" [Eur. J. Pharmacol. 1032 (2026) 179224].

Journal: European journal of pharmacology
Published: August 31, 2026

IL-10-producing innate lymphoid cells restrain γδT17-driven psoriatic inflammation.

IL-10-producing innate lymphoid cells restrain γδT17-driven psoriatic inflammation.

Journal: iScience
Published: February 10, 2026

X-linked spondyloepiphyseal dysplasia tarda misdiagnosed as growth hormone deficiency: identification of a novel intronic TRAPPC2 variant by whole-genome sequencing.

X-linked spondyloepiphyseal dysplasia tarda misdiagnosed as growth hormone deficiency: identification of a novel intronic TRAPPC2 variant by whole-genome sequencing.

Journal: BMC pediatrics
Published: February 09, 2026

ABRL8301, a Novel 2-Methoxyestradiol Derivative, Mitigates Progressive Pulmonary Fibrosis by Downregulating 11β-Hydroxysteroid Dehydrogenase 1.

ABRL8301, a Novel 2-Methoxyestradiol Derivative, Mitigates Progressive Pulmonary Fibrosis by Downregulating 11β-Hydroxysteroid Dehydrogenase 1.

Journal: European journal of pharmacology
Published: February 09, 2026

MG-101, a cysteine protease inhibitor identified through high-throughput screening, exhibits in vivo efficacy and synergy with remdesivir against SARS-CoV-2.

MG-101, a cysteine protease inhibitor identified through high-throughput screening, exhibits in vivo efficacy and synergy with remdesivir against SARS-CoV-2.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 30, 2025

Peritoneal mast cell-derived IL-10 promotes peritoneal-colon tolerance by reprogramming macrophages to ameliorate colitis.

Peritoneal mast cell-derived IL-10 promotes peritoneal-colon tolerance by reprogramming macrophages to ameliorate colitis.

Journal: Scientific reports
Published: November 24, 2025

Recurrent Hemorrhagic Stroke and Microcephaly in a Newborn with Aicardi-Goutières Syndrome Caused by a Homozygous Intronic RNASEH2B Variant.

Recurrent Hemorrhagic Stroke and Microcephaly in a Newborn with Aicardi-Goutières Syndrome Caused by a Homozygous Intronic RNASEH2B Variant.

Journal: Annals of clinical and laboratory science
Published: August 01, 2025

A vaccine targeting lung resident-memory CD4+ T cell phenotype protects against Mycobacterium tuberculosis in mice.

A vaccine targeting lung resident-memory CD4+ T cell phenotype protects against Mycobacterium tuberculosis in mice.

Journal: NPJ vaccines
Published: April 04, 2025

Relationship between cerebrospinal fluid cytokines/chemokines and clinical impact of myelin oligodendrocyte glycoprotein antibody-associated disorders in children.

Relationship between cerebrospinal fluid cytokines/chemokines and clinical impact of myelin oligodendrocyte glycoprotein antibody-associated disorders in children.

Journal: Brain & development
Published: March 05, 2025

Neuroimaging of patients with headache in the pediatric emergency department: A single center retrospective study.

Neuroimaging of patients with headache in the pediatric emergency department: A single center retrospective study.

Journal: Pediatrics and neonatology
Published: July 10, 2024

A combined adjuvant and ferritin nanocage based mucosal vaccine against Streptococcus pneumoniae induces protective immune responses in a murine model.

A combined adjuvant and ferritin nanocage based mucosal vaccine against Streptococcus pneumoniae induces protective immune responses in a murine model.

Journal: Nature communications
Published: June 04, 2024

IL-10+ regulatory B cells mitigate atopic dermatitis by suppressing eosinophil activation.

IL-10+ regulatory B cells mitigate atopic dermatitis by suppressing eosinophil activation.

Journal: Scientific reports
Published: May 29, 2024
Showing 1-12 of 147

Last Updated: 09/26/2026